학술논문

Mid-regional proadrenomedullin (MR-proADM), Creactive protein (CRP) and other biomarkers in the early identification of disease progression in patients with COVID-19 in the acute NHS setting.
Document Type
Article
Source
Journal of Clinical Pathology; Jun2023, Vol. 76 Issue 6, p400-406, 8p
Subject
COVID-19
C-reactive protein
DISEASE progression
CAPILLARY leak syndrome
TERMS of service (Internet)
NEUTROPHILS
LYMPHOCYTE count
Language
ISSN
00219746